Search results
Results from the WOW.Com Content Network
Cobalt therapy is the medical use of gamma rays from the radioisotope cobalt-60 to treat conditions such as cancer. Beginning in the 1950s, cobalt-60 was widely used in external beam radiotherapy (teletherapy) machines, which produced a beam of gamma rays which was directed into the patient's body to kill tumor tissue.
Cobalt-60 (60 Co) is a synthetic radioactive isotope of cobalt with a half-life of 5.2714 years. [ 3 ] [ 4 ] : 39 It is produced artificially in nuclear reactors . Deliberate industrial production depends on neutron activation of bulk samples of the monoisotopic and mononuclidic cobalt isotope 59
Acute radiation syndrome (ARS), also known as radiation sickness or radiation poisoning, is a collection of health effects that are caused by being exposed to high amounts of ionizing radiation in a short period of time. [ 1 ] Symptoms can start within an hour of exposure, and can last for several months. [ 1 ][ 3 ][ 5 ] Early symptoms are ...
Cobalt-60 (60 Co) is a synthetic radioactive isotope of cobalt, with a half-life of 5.27 years, and emits highly penetrating gamma rays. It is commonly used as a radiation source for radiotherapy and equipment sterilization in hospital settings, and also has industrial uses.
Leo Szilard (/ ˈsɪlɑːrd /; Hungarian: Szilárd Leó [ˈsilaːrd ˈlɛoː]; born Leó Spitz; February 11, 1898 – May 30, 1964) was a Hungarian-born physicist, biologist and inventor who made numerous important discoveries in nuclear physics and the biological sciences. He conceived the nuclear chain reaction in 1933, and patented the idea ...
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
It is estimated that almost 80 percent of people received a dose less than 500 mrem (equivalent to 5 mSv); 18 percent, between 0.5 and 25 rems (5–25 mSv); and only two percent (about 80 people) received doses greater than 25 rems (250 mSv). Of these, five people received a dose between 300 and 700 rems (3–7 Sv) over a period of two months. [3]